[go: up one dir, main page]

MX2017011312A - Metodos para la cuantificacion de los niveles de insulina por espectrometria de masas. - Google Patents

Metodos para la cuantificacion de los niveles de insulina por espectrometria de masas.

Info

Publication number
MX2017011312A
MX2017011312A MX2017011312A MX2017011312A MX2017011312A MX 2017011312 A MX2017011312 A MX 2017011312A MX 2017011312 A MX2017011312 A MX 2017011312A MX 2017011312 A MX2017011312 A MX 2017011312A MX 2017011312 A MX2017011312 A MX 2017011312A
Authority
MX
Mexico
Prior art keywords
methods
mass spectrometric
quantification
mass spectrometry
insulin levels
Prior art date
Application number
MX2017011312A
Other languages
English (en)
Other versions
MX386528B (es
Inventor
w taylor Steven
E Reitz Richard
Chen Zhaohui
J Clarke Nigel
Mcphual Michael
Original Assignee
Quest Diagnostics Invest Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quest Diagnostics Invest Llc filed Critical Quest Diagnostics Invest Llc
Publication of MX2017011312A publication Critical patent/MX2017011312A/es
Publication of MX386528B publication Critical patent/MX386528B/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/62—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating the ionisation of gases, e.g. aerosols; by investigating electric discharges, e.g. emission of cathode
    • G01N27/64—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating the ionisation of gases, e.g. aerosols; by investigating electric discharges, e.g. emission of cathode using wave or particle radiation to ionise a gas, e.g. in an ionisation chamber
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
    • G01N2030/8813—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/62—Insulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2560/00—Chemical aspects of mass spectrometric analysis of biological material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/62—Detectors specially adapted therefor
    • G01N30/72—Mass spectrometers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Ecology (AREA)
  • Endocrinology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Electrochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)

Abstract

Se describen métodos para determinar la cantidad de insulina en una muestra. En el presente documento se proporcionan métodos espectrométricos de masas para detectar y cuantificar insulina y péptido C en una muestra biológica al utilizar métodos de enriquecimiento y/o purificación acoplados con técnicas espectrométricas de masas en tándem o técnicas espectrométricas de masas de alta resolución/alta exactitud. También en el presente documento se proporcionan métodos espectrométricos de masas para detectar y cuantificar insulina y cadena B en una muestra biológica al utilizar métodos de enriquecimiento y/o purificación acoplados con técnicas espectrométricas de masas en tándem o técnicas espectrométricas de masas de alta resolución/alta exactitud.
MX2017011312A 2015-03-03 2016-03-03 Metodos para la cuantificacion de los niveles de insulina por espectrometria de masas. MX386528B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562127770P 2015-03-03 2015-03-03
US201562128236P 2015-03-04 2015-03-04
PCT/US2016/020723 WO2016141204A1 (en) 2015-03-03 2016-03-03 Methods for quantitation of insulin levels by mass spectrometry

Publications (2)

Publication Number Publication Date
MX2017011312A true MX2017011312A (es) 2018-04-30
MX386528B MX386528B (es) 2025-03-04

Family

ID=56848765

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017011312A MX386528B (es) 2015-03-03 2016-03-03 Metodos para la cuantificacion de los niveles de insulina por espectrometria de masas.

Country Status (8)

Country Link
US (3) US10324082B2 (es)
EP (2) EP3265805B1 (es)
JP (1) JP2018511812A (es)
CN (2) CN116298029A (es)
BR (1) BR112017018821B1 (es)
CA (1) CA2978570C (es)
MX (1) MX386528B (es)
WO (1) WO2016141204A1 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3920207A1 (en) * 2010-12-28 2021-12-08 Quest Diagnostics Investments LLC Quantitation of insulin by mass spectrometry
US10704021B2 (en) 2012-03-15 2020-07-07 Flodesign Sonics, Inc. Acoustic perfusion devices
EP3875959A1 (en) * 2012-12-26 2021-09-08 Quest Diagnostics Investments Incorporated C peptide detection by mass spectrometry
CN105939767B (zh) 2014-01-08 2018-04-06 弗洛设计声能学公司 具有双声电泳腔的声电泳装置
US10324082B2 (en) * 2015-03-03 2019-06-18 Quest Diagnostics Investments Llc Methods for quantitation of insulin levels by mass spectrometry
US11377651B2 (en) 2016-10-19 2022-07-05 Flodesign Sonics, Inc. Cell therapy processes utilizing acoustophoresis
US11708572B2 (en) 2015-04-29 2023-07-25 Flodesign Sonics, Inc. Acoustic cell separation techniques and processes
KR20180103961A (ko) * 2016-01-23 2018-09-19 바이오콘 리미티드 인슐린 유사체에 대한 생물학적 분석 방법
US11214789B2 (en) 2016-05-03 2022-01-04 Flodesign Sonics, Inc. Concentration and washing of particles with acoustics
CN118883748A (zh) * 2017-03-31 2024-11-01 奎斯特诊断投资有限公司 用于定量胰岛素和c-肽的方法
EP3422005B1 (en) * 2017-06-27 2020-05-13 Medizinische Universität Graz Determining enrichments of tracers of glucose by mass spectrometry
AU2018385759B2 (en) 2017-12-14 2021-10-21 Flodesign Sonics, Inc. Acoustic transducer driver and controller
CA3094080A1 (en) 2018-03-16 2019-09-19 Quest Diagnostics Investments Llc Methods for detecting chromogranin a by mass spectrometry
CN108693280A (zh) * 2018-08-23 2018-10-23 重庆美莱德生物医药有限公司 通过uplc-ms/ms定量测定生物样品中德谷胰岛素含量的方法
CN109061196A (zh) * 2018-09-25 2018-12-21 王毅超 一种基于硅纳米颗粒-质谱联合检测胰岛素的方法
CN109991351A (zh) * 2019-03-27 2019-07-09 苏州旭辉检测有限公司 一种血液样本中胰岛素类似物的检测方法
CA3141783A1 (en) * 2019-05-31 2020-12-03 Shin Nippon Biomedical Laboratories, Ltd. Mass spectrometry method using chromatography-mass spectrometry device
CN113075342B (zh) * 2020-01-04 2024-02-27 东莞市东阳光仿制药研发有限公司 一种分离检测德谷胰岛素侧链有关物质的方法
CN111366646B (zh) * 2020-02-27 2022-09-23 苏州新波生物技术有限公司 一种基于免疫纯化结合质谱检测的25-羟维生素d分析方法
EP4511651A1 (en) * 2022-04-20 2025-02-26 Siemens Healthcare Diagnostics, Inc. Quantitation of alkylphenol ethoxylate compounds in aqueous samples
CN115963194B (zh) * 2022-10-26 2024-09-03 中国计量科学研究院 一种基于特征性肽段同位素稀释质谱法的胰岛素定量方法
CN116183801A (zh) * 2023-04-11 2023-05-30 骏实生物科技(上海)有限公司 检测胰岛素和c肽的液相色谱-质谱方法、试剂盒和系统

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5605798A (en) 1993-01-07 1997-02-25 Sequenom, Inc. DNA diagnostic based on mass spectrometry
EP0700521B1 (en) 1993-05-28 2003-06-04 Baylor College Of Medicine Method and mass spectrometer for desorption and ionization of analytes
US5772874A (en) 1995-11-02 1998-06-30 Cohesive Technologies, Inc. High performance liquid chromatography method and apparatus
ES2140209T3 (es) 1996-01-19 2000-02-16 Cohesive Tech Inc Procedimiento y dispositivo de cromatografia de liquidos de alto rendimiento.
GB9717926D0 (en) 1997-08-22 1997-10-29 Micromass Ltd Methods and apparatus for tandem mass spectrometry
EP1050065A4 (en) 1998-01-23 2004-03-31 Analytica Of Branford Inc SURFACES MASS
US6680203B2 (en) 2000-07-10 2004-01-20 Esperion Therapeutics, Inc. Fourier transform mass spectrometry of complex biological samples
GB2404784B (en) 2001-03-23 2005-06-22 Thermo Finnigan Llc Mass spectrometry method and apparatus
EP1481416B1 (de) 2002-02-28 2016-06-15 Metanomics GmbH & Co. KGaA Massenspektrometrisches verfahren zur analyse von substanzgemischen
WO2006110644A2 (en) 2005-04-05 2006-10-19 Protein Discovery, Inc. Improved methods and devices for concentration and fractionation of analytes for chemical analysis including matrix-assisted laser desorption/ionization (maldi) mass spectrometry (ms)
JP2008540573A (ja) 2005-05-13 2008-11-20 マイクロビア インコーポレーテッド ４−ビアリーリル−１−フェニラゼチジン−２−オン類
JP2009540856A (ja) 2006-06-27 2009-11-26 バイオリポックス エービー エオキシン形成の修飾物質の同定方法
AU2007319437B2 (en) 2006-11-09 2013-01-10 Alcon Research, Ltd. Punctal plug comprising a water-insoluble polymeric matrix
US9091695B2 (en) 2007-06-01 2015-07-28 Laboratory Corporation Of America Holdings Methods and systems for quantification of peptides and other analytes
US20090035807A1 (en) * 2007-07-31 2009-02-05 Wyeth Analysis of polypeptide production
CA2707492A1 (en) 2007-12-13 2009-06-18 Amgen Inc. Gamma secretase modulators
EP2283349A1 (en) 2008-04-29 2011-02-16 Becton, Dickinson & Company Method and system for measuring a sample to determine the presence of and optionally treat a pathologic condition
EP2438085A1 (en) 2009-06-05 2012-04-11 McMaster University Synthesis and use of radiolabelled insulin analogues
EP3920207A1 (en) 2010-12-28 2021-12-08 Quest Diagnostics Investments LLC Quantitation of insulin by mass spectrometry
US8669519B2 (en) 2011-12-05 2014-03-11 Quest Diagnostics Investments, Inc. Methods for detecting reverse triiodothyronine by mass spectrometry
CN103454433B (zh) * 2012-06-05 2016-08-03 许洋 一种新型检测内外源性胰岛素的免疫质谱试剂盒
EP3875959A1 (en) 2012-12-26 2021-09-08 Quest Diagnostics Investments Incorporated C peptide detection by mass spectrometry
US10324082B2 (en) * 2015-03-03 2019-06-18 Quest Diagnostics Investments Llc Methods for quantitation of insulin levels by mass spectrometry

Also Published As

Publication number Publication date
US20160282328A1 (en) 2016-09-29
EP3796004A1 (en) 2021-03-24
US11486874B2 (en) 2022-11-01
US20190302095A1 (en) 2019-10-03
US20230184740A1 (en) 2023-06-15
WO2016141204A1 (en) 2016-09-09
CN116298029A (zh) 2023-06-23
CN107548460A (zh) 2018-01-05
BR112017018821B1 (pt) 2022-07-26
CA2978570C (en) 2023-09-19
EP3265805B1 (en) 2020-11-11
BR112017018821A2 (pt) 2018-04-24
MX386528B (es) 2025-03-04
EP3265805A1 (en) 2018-01-10
EP3265805A4 (en) 2018-08-15
JP2018511812A (ja) 2018-04-26
US10324082B2 (en) 2019-06-18
CA2978570A1 (en) 2016-09-09
EP3796004B1 (en) 2023-07-12

Similar Documents

Publication Publication Date Title
MX2017011312A (es) Metodos para la cuantificacion de los niveles de insulina por espectrometria de masas.
Berlioz-Barbier et al. Multi-residue analysis of emerging pollutants in benthic invertebrates by modified micro-quick-easy-cheap-efficient-rugged-safe extraction and nanoliquid chromatography–nanospray–tandem mass spectrometry analysis
WO2020047010A3 (en) Increasing spatial array resolution
CL2017001940A1 (es) Dispositivo de medición de la calidad del suelo
BR112018069849A2 (pt) kit, dispositivo e método para a detecção de câncer pancreático precoce ou de lesão precursora do câncer pancreático
BR112016027475A2 (pt) kit, dispositivo e método para a detecção de câncer pancreático
BR112015017473A2 (pt) método para detectar um agente patogênico em uma amostra, e, kit de análise de agente patogênico
MX2021014426A (es) Determinacion de antidepresivos por medio de espectrometria de masas.
AR053948A1 (es) Deteccion de un antigeno diana independientemente de la presencia o ausencia de un anticuerpo terapeutico correspondiente
BR112016029634A2 (pt) kit, dispositivo e método para a detecção de câncer de fígado
BR112016029521A2 (pt) ?kit, dispositivo e método para a detecção de câncer de estômago?
WO2018183966A3 (en) METHODS OF QUANTIFICATION OF INSULIN AND PEPTIDE C
BR112013015504A2 (pt) dispositivo de amostragem para um espectrômetro de migração de íon, método para introduzir uma amostra de gás a ser detectada pelo uso do dispositivo, e, espectrômetro de migração de íon
BR112018010161A8 (pt) sistema e método para avaliar um detector em um dispositivo de imagem
BRPI0811536B8 (pt) método para detectar uma cetona biologicamente ativa e método para extração
BR112014012366A2 (pt) processos para a detecção de triiodotironina inversa por espectrometria de massa
BR112016006312A2 (pt) método e kit para determinar a presença ou ausência de staphylococcus aureus resistente à meticilina em uma amostra biológica
ES2684758T3 (es) Procedimiento para diagnosticar fibrosis hepática
MX2016001719A (es) Metodos y equipos para predecir el riesgo de tener una enfermedad o evento cardiovascular.
MX2019005697A (es) Medicion de longitud de onda secuencial multiple de una muestra liquida.
BR112016024730A2 (pt) dispositivo, método e conjunto de análise imunocromatográfica
MX2016011807A (es) Membrana sensible al magnesio para un electrodo potenciometrico de ion selectivo para medicion de magnesio ionizado y metodos de produccion y uso de la misma.
AR098472A1 (es) Método para determinar un inhibidor de incrustaciones de una muestra
WO2013026026A3 (en) Shift correction for spectral analysis
CO6700864A2 (es) Cuantificación y caracterización de alérgenos